U0126

U0126 has been studied in 2 papers since 2016: none in people yet, 2 in animals. The research so far is in animals. The newest paper, Jul 29, 2021: “Obesity increases neuropathic pain via the AMPK-ERK-NOX4 pathway in rats”.

InterventionPreclinical

2 papers study it13 more mention it5 findingsUpdated

PubChemChEBI

1 new paper in 30 daysSee all 15 papers on U0126

At a glance

The findings reach mice, none yet in people. 4 independent labs in 4 countries.

1 of its findings points the other way.

Cells and mice: a single group. Worms or flies and humans: nothing yet.
  • 4 independent labs in 4 countries
  • 1 finding against
  • Funders: Institute for Intelligent Healthcare, Tsinghua University and others
  • Animals2

What did studies of U0126 find?

4

Studies of U0126 measured 4 outcomes, among them muscle regeneration, NOX4 and neuropathic pain.

Muscle regeneration

upin mice1downin zebrafish1

2 studies
  1. U0126 improves muscle regeneration in mice after injury.

    “ERK inhibition by U0126 not only induced recovery of myotube formation in old myoblasts but also facilitated muscle regeneration after injury in aged muscle.”

    Animalsafter injuryskeletal muscle

    Age-associated repression of type 1 inositol 1, 4, 5-triphosphate receptor impairs muscle regeneration

    Aging

  2. U0126 impairs muscle regeneration in injured extraocular muscle.

    “inhibition of MEK activity with U0126 mimicked the phenotype of the Fgf receptor inhibition on both muscle regeneration and cell proliferation”

    Animalsin injured extraocular muscleextraocular muscle

    Fgf regulates dedifferentiation during skeletal muscle regeneration in adult zebrafish

    Cellular signalling

NOX4

downin rat cells1

1 study
  1. U0126 decreases NOX4 in palmitic acid-treated DRG neurons.

    “while U0126 partially attenuated the PA-induced upregulation of NOX4 and other pathological changes.”

    Cellsin palmitic acid-treated DRG neurons

    Obesity increases neuropathic pain via the AMPK-ERK-NOX4 pathway in rats

    Aging

More on NOX4

Neuropathic pain

downin rats1

1 study
  1. U0126 decreases neuropathic pain in obese CCD rats.

    “Administration of U0126 could partially elevate the PWMT and reduce the protein expression of NOX4 and the above pathological changes in obese CCD rats.”

    Animalsin obese CCD rats

    Obesity increases neuropathic pain via the AMPK-ERK-NOX4 pathway in rats

    Aging

More on Neuropathic pain

P16 expression

downin mouse cells1

1 study
  1. U0126 decreases P16 expression in lower-dose Ang II and Aβ combination treatment.

    “These changes by lower dose combination, except in p-IκB expression and NF-κB activity, were significantly inhibited by pretreatment with U0126 (ERK inhibitor)”

    Cellsin lower-dose Ang II and Aβ combination treatmentbrain vascular smooth muscle cell4 daysmales

    Angiotensin II and Amyloid-β Synergistically Induce Brain Vascular Smooth Muscle Cell Senescence

    American journal of hypertension

More on P16 expression

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 02 papers in 12 months

See all 15 papers on U0126